RAB8A a new biomarker for endometrial cancer?

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Bie, Yachun ^a   Zhang, Zhenyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Dendritic cells (DCs); Endometrial cancer (EC); LC MS MS; Proteomic analysis; Tumor lysate

Indexed keywords

B7 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; RAS PROTEIN; RAS RELATED PROTEIN RAB 8A; TUMOR MARKER; UNCLASSIFIED DRUG; RAB PROTEIN; RAB8A PROTEIN, HUMAN;

ARTICLE; CELL LYSATE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOMETRIUM CANCER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD; WESTERN BLOTTING; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FETUS BLOOD; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; DENDRITIC CELLS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FETAL BLOOD; HUMANS; LYMPHOCYTE ACTIVATION; PROGNOSIS; PROTEOMICS; RAB GTP-BINDING PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84924189262     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-371     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106-130. 10.3322/canjclin.56.2.106
2. Kawakami Y, Fujita T, Matsuzaki Y, Sakurai T, Tsukamoto M, Toda M, Sumimoto H: Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. Cancer Sci 2004, 95:784-791. 10.1111/j.1349-7006.2004.tb02182.x
3. Schuler G, Schuler-Thurner B, Steinman RM: The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003, 15:138-147. 10.1016/S0952-7915(03)00015-3
4. Alaniz L, Rizzo MM, Mazzolini G: Pulsing dendritic cells with whole tumor cell lysates. Methods Mol Biol 2014, 1139:27-31. 10.1007/978-1-4939-0345-0_3
5. Com E, Evrard B, Roepstorff P, Aubry F, Pineau C: New insights into the rat spermatogonial proteome: identification of 156 additional proteins. Mol Cell Proteomics 2003, 2:248-261.
6. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
7. Keller A, Nesvizhskii AI, Kolker E, Aebersold R: Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392. 10.1021/ac025747h
8. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973, 137:1142-1162. 10.1084/jem.137.5.1142
9. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811. 10.1146/annurev.immunol.18.1.767
10. Zhu Y, Liu C, Tummala R, Nadiminty N, Lou W, Gao AC: RhoGDIalpha downregulates androgen receptor signaling in prostate cancer cells. Prostate 2013, 73:1614-1622.
11. Sakao K, Hahm ER, Singh SV: In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells. Nutr Cancer 2013,65(Suppl 1):61-67.
12. Jensen SS, Aaberg-Jessen C, Christensen KG, Kristensen B: Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas. Int J Clin Exp Pathol 2013, 6:1294-1305.
13. Rong F, Li W, Chen K, Li DM, Duan WM, Feng YZ, Li F, Zhou XW, Fan SJ, Liu Y, Tao M: Knockdown of RhoGDIalpha induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel. Neoplasma 2012, 59:541-550. 10.4149/neo_2012_070
14. Albrecht C, Huck V, Wehling M, Wendler A: In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1. Steroids 2012, 77:1543-1550. 10.1016/j.steroids.2012.09.006
15. Liao CL, Hsu JD, Lee MY, Kok LF, Li YJ, Wang PH, Yao CC, Han CP: Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough? Virchows Arch 2010, 456:377-386. 10.1007/s00428-010-0892-x
16. Ang AL, Taguchi T, Francis S, Folsch H, Murrells LJ, Pypaert M, Warren G, Mellman I: Recycling endosomes can serve as intermediates during transport from the Golgi to the plasma membrane of MDCK cells. J Cell Biol 2004, 167:531-543. 10.1083/jcb.200408165
17. Wiesner C, El Azzouzi K, Linder S: A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J Cell Sci 2013, 126:2820-2833. 10.1242/jcs.122358
18. Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A: Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet 2011, 80:305-318. 10.1111/j.1399-0004.2011.01724.x
19. Shen DW, Gottesman MM: RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm Res 2012, 29:643-650. 10.1007/s11095-011-0562-y
20. Sun Y, Bilan PJ, Liu Z, Klip A: Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc Natl Acad Sci U S A 2010, 107:19909-19914. 10.1073/pnas.1009523107